dr. brufsky on choosing when to do a multiparameter genomic assay
Published 7 years ago • 219 plays • Length 2:20Download video MP4
Download video MP3
Similar videos
-
1:19
dr adam brufsky: choosing a therapy for breast cancer patients
-
5:56
the complexity of choosing biosimilars in oncology
-
1:06
dr. brufsky on challenges in breast cancer
-
1:07
dr. brufsky on challenges facing biosimilars in breast cancer
-
0:54
dr. brufsky discusses reasons to use biosimilars in oncology
-
32:16
brain, heart & gut connection: 3 brains, 1 breath, 1 mind
-
3:20
identification of biomarker may lead to earlier detection of stomach cancer
-
2:13
when should you see a doctor about diarrhea?
-
7:42
breast cancer: genomic testing for adjuvant therapy
-
0:57
dr. brufsky on biosimilars being explored in oncology
-
1:01
dr. brufsky on trastuzumab biosimilars in breast cancer
-
1:22
dr. brufsky on cobimetinib plus paclitaxel in tnbc
-
1:15
dr. brufsky on reducing the cost of care in breast oncology
-
1:47
dr. brufsky on the risk covid-19 poses to patients with cancer
-
1:25
dr. brufsky addresses biosimilar skepticism
-
1:12
dr adam brufsky outlines care coordination in oncology
-
2:12
dr adam brufsky discusses value coordinates of breast cancer care
-
1:07
adam brufsky, md, phd: expectations of therapy in breast cancer
-
2:47
adam brufsky, md, phd: clinical trial data supporting these choices
-
2:29
finding the sweet spot: modeling gpcrs and discovery of ... - yaron ben-shoshan galeczki - abstract
-
12:02
adam brufsky, md: covid-19 and spike protein glycosylation